Wegovy Titration Costs $2,160-$2,280 Before Maintenance Dose in Canada

Canadian patients starting Wegovy face a 16-week titration schedule that costs $2,160 to $2,280 before reaching the 2.4 mg maintenance dose, because Novo Nordisk prices every Wegovy pen at a flat rate regardless of strength [Source: semaglutidecanada.com/wegovy/cost/].

The flat-price pen structure

A single Wegovy pen costs between $540 and $570 CAD per month at most Canadian pharmacies, with a dispensing fee of $10 to $12 bringing a typical fill to $550 to $582 [Source: semaglutidecanada.com/wegovy/cost/]. A separate retail tracker lists the range slightly wider, at $400 to $570 per month [Source: teletest.ca/cost/drug/wegovy/]. Pharmacy pricing data on GLP1Prices.ca currently shows Wegovy ranging from $270 to $490 CAD across 172 sample fills, with the lower end reflecting bulk-pen and discount-pharmacy pricing not always captured in retail surveys.

Wegovy uses a 5-step titration over 16 weeks before patients reach the 2.4 mg maintenance dose [Source: semaglutidecanada.com/wegovy/cost/]. Because pricing does not vary by strength, the monthly cost curve is linear:

• Month 1 (0.25 mg weekly): $540-$570
• Month 2 (0.5 mg weekly): $540-$570
• Month 3 (1.0 mg weekly): $540-$570
• Month 4 (1.7 mg weekly): $540-$570
• Month 5+ (2.4 mg maintenance): $540-$570

Cumulative spend reaches $2,160-$2,280 by the end of titration and climbs to $2,700-$2,850 after the first full maintenance month [Source: semaglutidecanada.com/wegovy/cost/]. One published estimate puts the annual out-of-pocket figure at approximately $5,066 CAD on the standard maintenance dose [Source: ogaei.ca/blog/wegovy-cost-in-canada/].

Bulk purchases and patient support

Some Canadian pharmacies offer reduced pricing on multi-pen orders. Purchasing three pens together can drop the per-pen cost to approximately $399 CAD, a discount described as saving $150 or more per month compared with single-pen purchases [Source: ogaei.ca/blog/wegovy-cost-in-canada/].

Novo Nordisk Canada's patient support resources include injection training, coaching, insurance-navigation help and, in some cases, financial assistance for patients with inadequate coverage [Source: semaglutidecanada.com/wegovy/cost/]. A separate retail listing notes the Novo Nordisk Care program may cover the full cost for patients without any drug plan, subject to eligibility [Source: teletest.ca/cost/drug/wegovy/].

No public coverage in any province

As of early 2026, no Canadian provincial health plan covers Wegovy when prescribed for weight management [Source: ogaei.ca/blog/wegovy-cost-in-canada/]. The Ontario Drug Benefit formulary does not list Wegovy, and the drug is flagged as not covered for retail tracking purposes [Source: teletest.ca/cost/drug/wegovy/].

The Canadian Drug Agency assessed Wegovy's cost-effectiveness in July 2025 and recommended a price reduction before public coverage could be justified [Source: ogaei.ca/blog/wegovy-cost-in-canada/]. In December 2025, negotiations between the pan-Canadian Pharmaceutical Alliance and Novo Nordisk concluded without agreement, with the manufacturer declining to negotiate on price [Source: ogaei.ca/blog/wegovy-cost-in-canada/]. Patients can use our insurance coverage checker to review what their private plan may include.

Generic semaglutide on the horizon

Novo Nordisk's data exclusivity on semaglutide expired January 4, 2026, and the key Canadian patent has lapsed [Source: semaglutidecanada.com/wegovy/cost/]. Health Canada has approved the first generic version of semaglutide, manufactured by Dr. Reddy's Laboratories, and the agency has stated that eight other submissions are currently under review [Source: globalnews.ca/news/11820779/canada-approves-1st-generic-ozempic-market/].

Under the pan-Canadian Pharmaceutical Alliance's generic drug framework, the first generic version of a medication typically costs 75 to 85 per cent less than the brand name [Source: globalnews.ca/news/11820779/canada-approves-1st-generic-ozempic-market/]. One retail tracker projects a generic semaglutide price band of $40 to $160 per month arriving in summer 2026 [Source: teletest.ca/cost/drug/wegovy/]. The first generics are diabetes-indicated Ozempic equivalents rather than direct Wegovy replacements, although the molecule is identical [Source: semaglutidecanada.com/wegovy/cost/]. Readers can follow application status on our generic semaglutide tracker.

Other GLP-1 prices in context

For context, Felix data cited by Global News puts Ozempic at $200-$450 per month and Mounjaro at $300-$550 per month across Canadian provinces [Source: globalnews.ca/news/11820779/canada-approves-1st-generic-ozempic-market/]. GLP1Prices.ca data shows Ozempic ranging from $222 to $663 and Mounjaro from $283.08 to $813 across larger sample sizes, reflecting wider pharmacy-to-pharmacy variation than the Felix range captures.

For additional pricing detail across Rybelsus, Zepbound and other GLP-1 products, see our Rybelsus and Zepbound pages or visit the FAQ.

This article is for informational purposes only and does not constitute medical advice.